The Valley Desk

Clinical trial reportJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerPublished

Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study

17 of 32 authors shown in byline order.

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published
Subject terms
Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Antibodies, Bispecific; Survival Rate; Mutation; Exons; Adult; Aged; Aged, 80 and over; Middle Aged; Female
PubMed ID
40383434
Added to directory
Source checked

Report a correction or request removal